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• Almost ten percent of older-adults experience an 
adverse drug reaction [ADR] associated with acute 
hospitalisation
• Individual studies suggest that up to 1 in 4 
experience an ADR in hospital. 
This systematic review [SR] aims to evaluate in-hospital 
ADRs in hospitalised older-adults; frequency, culprit 
drug classes, severity, and clinical consequence.
Methods
This SR was conducted Following the Preferred
Reporting Items for Systematic Reviews and Meta
Analyses (PRISMA) (Moher et al., 2009). Two
researchers (EJ, KM) screened all papers for inclusion,
risk of bias and data extraction independently.
Registration
• PROPSERO registration CRD42018079095
Search Strategy
• Databases – electronic databases [PubMed, Embase
and EBSCO-CINAHL, Cochrane Library] and library-
hosted academic sources, google scholar, and grey
literature.
• Search term stems – aged, ADRs, hospitalized, multi-
morbid, polypharmacy and hospital-acquired [search
strategy available on request from author]




• All dates up to and including the date of the final
search [15/01/2018] were eligible.
• Any study that reported on ADRs either as a primary
or secondary outcome in those aged 65 years or
older that were hospitalised at time of ADR
occurrence.
• Review articles, systematic reviews, case
reports and letters to the editor were
subsequently excluded – their bibliography
was hand searched for suitable studies.
• When data reported was for all ages, but there was
evidence of ≥65 cohort the author was contacted
requesting data for those aged 65 and over.
• A template document for completion was
provided.
• Two attempts were made to the listed
author, followed by an attempt to contact a
co-author.
Study Quality / Risk of Bias Assessment
Included studies were assessed for risk of bias and study
quality.
• Cochrane for randomised controlled trials
• STROBE checklist for case cohort studies
• Newcastle-Ottawa Scale for non-randomised studies
Data Extraction
We extracted data to assess percentage of study cohort
≥ 65 that experienced an ADR, reported presentation of
ADRs, Drugs deemed accountable, ADR severity, ADR
preventability, any measured outcomes.
Results
Study selection – see PRISMA Diagram [Figure 1.]
1930 abstracts were identified, 1,779 were screened, 228 underwent full-
text screening. 23 papers reporting 22 studies were included [1-23] 11 ADRs
in participants ≥ 65 years, 11 ADRs all age adults (extractable data for ≥65
available in 5 studies, supplemental data provided by authors in 6 studies)
Characteristics of Included Studies
21,306 patients were included in the 22 studies; 15,769 (74%) were aged
≥65 years. 50% male, 50% female (reported in 18 studies). Polypharmacy
(reported as a mean/median ≥5 medications at baseline) was reported and
present in 12 studies. Multi-morbidity (reported as a mean/median number
of diagnoses ≥3 at baseline) was reported in 9 and present in 8 studies.
ADR Rates
22 Studies reported ADR incidence – 2186 patients ≥ 65 years experienced
ADRs in-hospital. Median 19.77% [IQR 10.44 – 25.35] Min 4.95% Max
42.19%.
Reported ADR Presentation
16 studies reported on ADR presentation (n = 13,217, 1,403 ADR
presentations). 20% (283) metabolism and nutritional disorders; 17% (246)
nervous system disorders; 15% (210) cardiac disorders; 13% (185) gastro-
intestinal disorders; 10% (148) renal and urinary disorders; 6% (80) blood
and lymphatic system disorders.
ADR Drugs
ADR associated drugs were extractable in 15 papers (1528 reported drugs
in 1253 ADR patients). 85% of ADRs were associated with 11 commonly
prescribed medications.
ADR Severity
14 studies reported severity (n = 13,171; reported ADRs = 1,947). 72% of
reported ADRs were at least of moderate severity. 29% (560 ADRs) were
severe.
ADR Preventability
5 studies assessed preventability (n = 3602, reporting 672 ADRs), 69% of
reported ADRs were preventable.
Outcomes
5 papers reported on post ADR outcomes [3 length of stay [LOS], 1 LOS-
death, 1 functional decline].
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• There is a lack of consistency in methodologies used for ADR 
identification, assessment and reporting in the literature.
• Incident ADRs occurring in-hospital in older adults (≥ 65 years) are 
common, occurring in 1 in 5 hospitalised older adults.
• 11 commonly prescribed drug classes account for 85% of all ADRs.
• 1 in 4 of ADRs are severe.
• 2 of 3 ADRs could be preventable.
• Despite this, there is under-reporting of measurable clinical 
outcomes associated with ADRs.
• Development of drug based ADR prediction tools may lead to better 
ADR prevention. 
Figure 1. PRISMA Flowchart outlining study selection
Author contact: elmjennings@gmail.com
